ELIEM THERAPEUTICS INC (ELYM) Stock Analyst Earnings Estimates
NASDAQ:ELYM - Nasdaq - US28658R1068 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.45M | -20.93M -180.94% | -35.67M -70.43% | -45.14M -26.55% | -21.466M 52.45% | N/A -65.15% | N/A -49.29% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.72 73.28% | N/A 22.91% | N/A 60.00% | N/A -19.23% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.25 50.00% | -0.26 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.29 27.50% | -0.39 | 0.10 | 25.18% |
| Q3 2022 Q2Q % growth | -0.37 47.14% | -0.44 | 0.07 | 16.13% |
| Q2 2022 Q2Q % growth | -0.56 81.99% | -0.48 | -0.08 | -17.65% |
| Q1 2022 Q2Q % growth | -0.50 | -0.57 | 0.07 | 12.98% |
| Q4 2021 Q2Q % growth | -0.40 | -0.63 | 0.23 | 36.75% |
| Q3 2021 Q2Q % growth | -0.70 | -0.94 | 0.24 | 25.67% |
| Q2 2021 Q2Q % growth | -3.11 | -1.90 | -1.21 | -63.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |